ARCHIVES

Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors.

This article is from The Cancer Letter archive.

Vol. 34 No. 32 | September 5, 2008

Download PDF Visit The Full Archive

Related Articles

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas

January 1, 1993

Moffitt Ends Pilot Study Based On Duke Test, Says Action Unrelated

October 23, 2009

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990